SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BostonView who wrote (1967)1/12/1999 3:47:00 PM
From: Joe  Read Replies (1) of 4140
 
The best thing for you to do is to call shareholder relations at SNRS and get a copy of the PMG analysts' report and the Red Chip Review. (RCR is available as a .pdf on-line for $10.)

The stock price will be climbing prior to the FDA's Ophthalmic Device Panel in May 3rd and 4th (April has been mentioned but FDA has not scheduled an April meeting.) The TA folks on this thread might give you a clue if there will be any more buying opportunities below the $7 level. I would expect there to be some dips before the May meeting unless the company announces the start of clinicals on astigmatism or something of that magnitude.

Sorry for the short and simple response. Many on this thread are long time investors and have said it all before.

Good luck,

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext